(Q31881389)

4 July 2017

1 reference

title

Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity (English)

1 reference

4 July 2017

Griffin MR

1

1 reference

4 July 2017

Scheiman JM

series ordinal

2

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Medicine

4 July 2017

published in

1 reference

4 July 2017

volume

110

1 reference

4 July 2017

issue

1A

1 reference

4 July 2017

page(s)

33S-37S

1 reference

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Adverse drug reactions and the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Incidence of peptic ulcer disease in Gothenburg, 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Clinical aspects of renal prostaglandins and NSAID therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Another side effect of NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

The role of prostaglandins in human hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Prevalence and characteristics of multiple analgesic drug use in an elderly study group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Analgesic drug use in an ambulatory elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Guidelines for the medical management of osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Guidelines for the medical management of osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Prophylactic aspirin and risk of peptic ulcer bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900634-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(00)00634-3

1 reference

4 July 2017

1 reference